New Key Statistics Module, Z-Score and F-Score
NAS:BIIB Key Ratios
| Market Cap $ M | 43,228.76 |
| Enterprise Value $ M | 44,797.16 |
| P/E(ttm) | 13.87 |
| PE Ratio without NRI | 13.87 |
| Forward PE Ratio | 19.61 |
| Price/Book | 3.13 |
| Price/Sales | 4.30 |
| Price/Free Cash Flow | 30.58 |
| Price/Owner Earnings | 16.43 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 10,104.00 |
| EPS (TTM) $ | 21.54 |
| Beneish M-Score | -2.37 |
| 10-y EBITDA Growth Rate % | 10.10 |
| 5-y EBITDA Growth Rate % | -5.30 |
| y-y EBITDA Growth Rate % | 57.90 |
| EV-to-EBIT | 11.41 |
| EV-to-EBITDA | 10.03 |
| PEG | -- |
| Shares Outstanding M | 144.74 |
| Net Margin (%) | 30.99 |
| Operating Margin % | 27.49 |
| Pre-tax Margin (%) | 36.45 |
| Quick Ratio | 2.81 |
| Current Ratio | 3.24 |
| ROA % (ttm) | 12.76 |
| ROE % (ttm) | 24.82 |
| ROIC % (ttm) | 14.10 |
| Dividend Yield % | -- |
| Altman Z-Score | 4.62 |
| Piotroski F-Score | 7.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | Y |
| Cash flow > Earnings | N |
| Lower Leverage y-y | Y |
| Higher Current Ratio y-y | Y |
| Less Shares Outstanding y-y | Y |
| Gross Margin Increase y-y | Y |
| Higher Asset Turnover y-y | N |
BIIB Number of Guru Trades
BIIB Volume of Guru Trades
Gurus Latest Trades with NAS:BIIB
No Available Data
NAS:BIIB is held by these investors
Total 5
Biogen Inc Insider Transactions
No Available Data
News about NAS:BIIB
Total 0- 1
